Literature DB >> 15047089

Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer.

Liora Navon1, Amira Morag.   

Abstract

The hormonal treatment of advanced prostate cancer involves life disruptive side-effects, such as impotence, libido loss and bodily feminisation. Conflicting views on the weight of the disruption they cause as against the therapy's survival benefits currently underlie debates over its appropriate mode of administration and its optimal timing in cases that do not necessitate immediate intervention. On the basis of a study of the disruptions caused to various life domains of 15 Israeli patients receiving such treatment, the present paper illustrates an integrated approach to their analysis that sheds new light on their intensity. The study was conducted by means of in-depth interviews and its data were processed according to the constant comparative analysis method. Its findings indicate that the therapy allowed the patients to regain their strength, to retain their need of love, basic masculine self-identification and spousal ties, and to renew their past social contacts. On the other hand they could no longer define themselves as healthy, sexually competent and 'male' in all respects, and their pre-treatment relationships with partners and friends lost the sense of closeness. Further psychosocial costs that were detected include patients' deprivation of their sense of continuity, excitements, hopes and coping capabilities. An integrated analysis of the concurrent normalisation and deviantisation processes undergone by them yielded the conclusion that the therapy subjects them to a liminal state, that is, the inability to classify themselves into culturally available categories. The difficulties entailed in this state highlight the need to take them into consideration when patients' condition allows a choice between alternative forms of hormonal therapy and between its early or deferred commencement. The interpretation of the disruption to their lives in terms of liminality also clarifies former studies' confusing reference to this subject and points to issues that still await investigation.

Entities:  

Mesh:

Year:  2004        PMID: 15047089     DOI: 10.1016/j.socscimed.2003.08.029

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  Cancer as biographical disruption: constructions of living with cancer.

Authors:  Gill Hubbard; Liz Forbat
Journal:  Support Care Cancer       Date:  2011-11-11       Impact factor: 3.603

2.  Passing through the wall: on outings, exodus, angels, and the ark.

Authors:  Richard Joel Wassersug
Journal:  J Relig Health       Date:  2008-12-30

3.  The Effects of Social Support on Health-Related Quality of Life of Patients with Metastatic Prostate Cancer.

Authors:  Giuseppe Colloca; Pasquale Colloca
Journal:  J Cancer Educ       Date:  2016-06       Impact factor: 2.037

4.  Men with prostate cancer over the first year of illness: their experiences as biographical disruption.

Authors:  Sandi Cayless; Liz Forbat; Nicola Illingworth; Gill Hubbard; Nora Kearney
Journal:  Support Care Cancer       Date:  2009-04-07       Impact factor: 3.603

5.  Prostate cancer support groups: Canada-based specialists' perspectives.

Authors:  John L Oliffe; Suzanne Chambers; Bernie Garrett; Joan L Bottorff; Michael McKenzie; Christina S Han; John S Ogrodniczuk
Journal:  Am J Mens Health       Date:  2014-07-24

Review 6.  Ethnicity and the prostate cancer experience: a qualitative metasynthesis.

Authors:  Carol Rivas; Lauren Matheson; Johana Nayoan; Adam Glaser; Anna Gavin; Penny Wright; Richard Wagland; Eila Watson
Journal:  Psychooncology       Date:  2016-08-23       Impact factor: 3.894

7.  Threat of biographical disruption: the gendered construction and experience of infertility following cancer for women and men.

Authors:  Jane M Ussher; Janette Perz
Journal:  BMC Cancer       Date:  2018-03-05       Impact factor: 4.430

8.  Infection after knee replacement: a qualitative study of impact of periprosthetic knee infection.

Authors:  Charlotte M Mallon; Rachael Gooberman-Hill; Andrew J Moore
Journal:  BMC Musculoskelet Disord       Date:  2018-10-02       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.